Home/Rynd Biotech/Camille Dodd

CD

Camille Dodd

Co‑Founder & CEO

Therapeutic Areas

Rynd Biotech Pipeline

Drug	Indication	Phase
Rynd Urine Bladder Cancer Recurrence Test	Bladder Cancer Recurrence Monitoring	Phase 2

Leadership Team at Rynd Biotech

Hector G. Dorta, MSc

Co‑Founder & CSO

François‑Michel Boisvert, PhD

Chief Technical Officer

Dr. Claudio Jeldres, MD, MSc, FRCSC

Chief Medical Officer

View full Rynd Biotech profile